This book provides an overview of pulmonary hypertensive diseases, the current understanding of their pathobiology, and a contemporary approach to diagnosis and treatment. It discusses the definition and classification of these disorders and the epidemiology of pulmonary arterial hypertension (PAH); explores the approach to diagnosis and evaluation via methods such as echocardiography, right heart catheterization, and cardiopulmonary exercise testing; describes the major drug classes used to treat PAH and the cell signaling pathways that they target as well as adjunct and investigative therapies; and highlights special situations that are particularly challenging in the management of PAH. Written by experts in their respective fields, Diagnosis and Management of Pulmonary Hypertension is a valuable resource for pulmonologists, cardiologists, and practitioners in internal medicine and critical care.
Reihe
Auflage
Softcover Reprint of the Original 1st 2015 ed.
Sprache
Verlagsort
Zielgruppe
Illustrationen
45
47 farbige Abbildungen, 45 s/w Abbildungen
XIV, 474 p. 92 illus., 47 illus. in color.
Maße
Höhe: 235 mm
Breite: 155 mm
Dicke: 25 mm
Gewicht
ISBN-13
978-1-4939-5281-6 (9781493952816)
DOI
10.1007/978-1-4939-2636-7
Schweitzer Klassifikation
James R. Klinger, MD is a graduate of the Medical College of Wisconsin, Milwaukee, WI. He performed his residency at the Medical College of Pennsylvania, Philadelphia, PA and fellowship at Rhode Island Hospital and Brown University School of Medicine in pulmonary and critical care medicine. He is licensed and certified in internal medicine and critical care medicine. His teaching role includes being a lecturer in pulmonary pathophysiology as well as extensive hospital teaching roles at Rhode Island Hospital for house staff and pulmonary fellows. Klinger's numerous publications can be viewed in Chest, the Journal of Applied Physiology, American Journal of Respiratory Critical Care Medicine, American Journal of Medicine, and many more. His research concerns development of therapies to treat pulmonary hypertension as well as research in the field of blood clotting, which can be one cause of pulmonary hypertension. Klinger is an active speaker and expert in the field of pulmonary hypertension and has many speaking engagements across the country.
